Top Sell
| Security ▲ | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Accelerate Diagnostics Inc. | 1 | 1 | 0 | 0 | €0.88 | - | - |
| Agenus Inc. | 3 | 2 | 1 | 0 | €0.41 | €22.25 | 5276.897% |
| Anavex Life Sciences Corp | 0 | 2 | 0 | 0 | €4.12 | - | - |
| Aspira Womens Health Inc. | 0 | 1 | 0 | 0 | €2.34 | - | - |
| Atara Biotherapeutics Inc. | 2 | 3 | 0 | 0 | €0.56 | €3.00 | 431.915% |
| Avinger Inc. | 2 | 7 | 0 | 0 | €0.34 | €4.64 | 1272.633% |
| Bellicum Pharmaceuticals Inc. | 0 | 13 | 0 | 0 | €0.064 | - | - |
| Coherus Bioscien. | 2 | 2 | 0 | 0 | €1.96 | €3.00 | 53.453% |
| Cytomx Therapeutics Inc | 1 | 2 | 1 | 2 | €1.74 | €25.50 | 1362.995% |
| Eagle Pharmaceuticals Inc | 0 | 1 | 0 | 0 | €4.44 | - | - |
| Enzo Biochem. Inc. | 0 | 1 | 0 | 0 | €1.00 | - | - |
| Fate Therapeutics Inc. | 4 | 3 | 1 | 1 | €3.59 | €8.27 | 130.128% |
| Gritstone Oncology Inc | 3 | 2 | 1 | 0 | €0.69 | €6.43 | 834.520% |
| Minerva Neurosciences Inc. | 1 | 5 | 0 | 1 | €2.34 | €3.00 | 28.205% |
| Ocuphire Pharma Inc. | 6 | 1 | 1 | 0 | €1.55 | €18.37 | 1084.903% |
| Omeros Corp. | 2 | 4 | 0 | 0 | €3.13 | - | - |
| Orasure Tech | 3 | 1 | 0 | 0 | €4.78 | €8.36 | 74.860% |
| Organovo Holdings Inc. | 0 | 7 | 0 | 2 | €0.95 | €3.00 | 215.126% |
| Pacific Biosciences of California Inc. | 10 | 5 | 1 | 1 | €1.87 | €10.20 | 446.700% |
| Palisade Bio Inc. | 3 | 1 | 1 | 0 | €0.34 | €21.06 | 6072.333% |
| Revance Therapeutics Inc. | 1 | 2 | 0 | 2 | €2.78 | €3.50 | 25.899% |
| Salarius Pharmaceuticals Inc. | 0 | 1 | 0 | 0 | €0.41 | - | - |
| Savara Inc. | 1 | 1 | 0 | 1 | €4.62 | €8.00 | 73.160% |
| Synthetic Biologics Inc. | 0 | 1 | 0 | 1 | €0.35 | - | - |
| T2 Biosystems Inc. | 0 | 11 | 0 | 0 | €0.16 | - | - |